BioFab Ltd
Manchester
About BioFab Ltd
BioFab is developing innovative new products for healthcare diagnostics with a particular focus on point-of-care testing (POCT) applications. Our vision is to create a truly universal diagnostic platform that can bring the clinical lab to the patient. Our innovative approach will enable this vision by offering a diverse range of test cartridges which can run on a single, universal reader device. It will not need any user training and will simply require the addition of the patient sample. Fully automated processing will then take place in a totally enclosed cartridge and will then deliver laboratory grade results without risk of cross-contamination. We are developing a test for Covid-19 with the support of an Innovate UK Smart award and will expand the product range to cover cardio-vascular disease, respiratory/gastric infections, blood infections (sepsis), STDs, Cancer and other conditions. We also have the ability to access the rapidly expanding Chinese market and have route-to-market and manufacturing base via established partners in China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $433.3K
- Funding stage: Seed
- Last round: Grant (Sep 2020)
- Website: biofab.co.uk
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/biofab-ltd-359 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.